Dual treatment with atazanavir–ritonavir plus lamivudine versus triple treatment with atazanavir–ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial
Titel:
Dual treatment with atazanavir–ritonavir plus lamivudine versus triple treatment with atazanavir–ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial
Auteur:
Perez-Molina, José A Rubio, Rafael Rivero, Antonio Pasquau, Juan Suárez-Lozano, Ignacio Riera, Melcior Estébanez, Miriam Santos, Jesús Sanz-Moreno, José Troya, Jesús Mariño, Ana Antela, Antonio Navarro, Jordi Esteban, Herminia Moreno, Santiago